Author: kgcooper

Shark antibody-like proteins neutralize COVID-19 virus, help prepare for future coronaviruses

Christina Scribano (recent PhD graduate in Weaver Lab) published a study in Science Translational Medicine that elucidates how a commonly-used cancer drug called paclitaxel works in some patients with breast cancer. Though often used as a cancer treatment, paclitaxel is not effective for all patients. Prior to this study the mechanism by which it works …

Sarah Copeland (Weaver Lab) was awarded first place for her poster in the Cancer Pharmacology Division at the ASPET EB2021 conference in April 2021! She was funded to attend the conference by the MCP Virtual Conference award. Link to the poster award announcement.  

Sascha Mueller (Kalin Lab) was recently one of the first authors in a study published recently in the journal Molecular Therapy, where they described a new method that could alter the function of specific cells in brain circuits implicated in anxiety and other types of psychiatric disorders, and lead to new, less invasive treatments. The …

Congratulations to Kalina Reese (Ge Lab) who was recently awarded by The National Science Foundation Graduate Research Fellowship Program ( NSF GRFP). The program is awarded to students pursuing research based masters and doctoral degrees in STEM. This five year fellowship provides three years of financial support, cost of education allowance, and professional development. Kalina’s …

Dr. Debra Garvey, UW–Madison Post-doctoral Researcher in Dr. Will Ricke‘s lab, and Alexis Adrian, UW–Madison Molecular and Cellular Pharmacology graduate student in Dr. Will Ricke’s lab, have been appointed as O’Brien Center Representatives to the CAIRIBU Trainee & Early Investigator Community.  In addition, UW/UTSW/U.Mass-Boston O’Brien Center trainees Dr. Debra Garvey (UW, Ricke Lab) and Dr. …